Kilitch Drugs(I) Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Kilitch Drugs(I) Ltd. on BSE

Load latest

Kilitch Drugs(I) Ltd.

29 Apr 2024

337.05

-1.73%

Corp. Note

KILITCH DRUGS (INDIA) LTD. - 524500 - Format of the Initial Disclosure to be made by …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyKILITCH DRUGS (INDIA) LTD. 2CIN NO.L24239MH1992PLC066718 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Pushpa Nyoupane Designation: Company Secretary and Compliance Officer EmailId: pushpanyoupane@kilitch.com Name of the Chief Financial Officer: Sunil Jain Designation: Chief Financial Officer EmailId: suniljain@kilitch.com Date: 29/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Kilitch Drugs(I) Ltd.

24 Apr 2024

337.05

-1.73%

Corp. Note

KILITCH DRUGS (INDIA) LTD. - 524500 - Compliances-Reg. 39 (3) - Details of Loss of Certificate …

BSE India

Intimation of Issue of Duplicate share certificate to shareholders. Details attached.

pdf

Kilitch Drugs(I) Ltd.

15 Apr 2024

337.05

-1.73%

Company Update

KILITCH DRUGS (INDIA) LTD. - 524500 - Certificate Under Regulation 40(10) Of SEBI(Listing Obligations And Disclosure …

BSE India

Enclosing the certificate received from Practicing Company Secretary under regulation 40(10) of SEBI (Listing Obligations and Disclosure Requirements) Regulatitons, 2015

pdf

Kilitch Drugs(I) Ltd.

10 Apr 2024

337.05

-1.73%

Company Update

KILITCH DRUGS (INDIA) LTD. - 524500 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

Compliance Certificate under regulation 74(5) of SEBI (DP) Regulation, 2018

pdf

Kilitch Drugs(I) Ltd.

10 Apr 2024

337.05

-1.73%

Company Update

KILITCH DRUGS (INDIA) LTD. - 524500 - Certificate Under Regulation 7(3) Of LODR For The Period …

BSE India

Compliance Certificate under regulation 7(3) of LODR for the period ended 31st March, 2024

pdf

Kilitch Drugs(I) Ltd.

30 Mar 2024

337.05

-1.73%

Corp. Note

KILITCH DRUGS (INDIA) LTD. - 524500 - Compliances-Reg. 39 (3) - Details of Loss of Certificate …

BSE India

Intimation to the exchange regarding issue of Duplicate Certificate

pdf

Kilitch Drugs(I) Ltd.

29 Mar 2024

337.05

-1.73%

Corp. Note

KILITCH DRUGS (INDIA) LTD. - 524500 - Compliances-Reg. 39 (3) - Details of Loss of Certificate …

BSE India

Intimation received from Link Intime India Private Limited, RTA of the Company regarding loss of share certificate by the shareholder

pdf

Kilitch Drugs(I) Ltd.

26 Mar 2024

337.05

-1.73%

SAST

KILITCH DRUGS (INDIA) LTD. - 524500 - Closure of Trading Window

BSE India

The trading window for dealing in securities of the Company will remain closed for all the designated person of the Company and their immediate relatives with effect from Monday 1st April, 2024 till expiry of 48 hours after declaration of the financial results for the quarter ended 31st March, 2024

pdf